The 14th International Conference on the Radiopharmaceutical Therapy (ICRT) will be held in Nanjing from August 21 to 24, 2019. This conference will offer to our Chinese and International Colleagues a unique opportunity to learn about the recent advances, exchange scientific experience in Nuclear Medicine therapy and molecular imaging as well as molecular targeting within a wonderful environment.

Nanjing is one of the oldest cities in China, dating back to 571 BC, and served as the capital city of several Chinese imperial dynasties. Today, Nanjing combines history, culture, tradition, and modernity. Its geographic location is strategic and located less than 2 hours by train from Shanghai. Its International Airport connects most international cities with direct flights, such as Tokyo and Frankfurt. Attendees and visitors may appreciate the Imperial Mausoleums, old temples, traditional gardens, City Wall and many other museums in Nanjing. Nanjing is among the leading Chinese cities for life science research with 74 colleges and universities; the Nanjing University, Southeast University, China Pharmaceutical University, and Nanjing Medical University are a few examples. 

The ICRT is the first meeting in the field of radiopharmaceutical therapy held in China, which turned into a prestigious international scientific event over the last decade. Throughout this meeting, the attendees of the ICRT-2019 will discover exciting and diverse scientific and social programs.

Date: August 21 to 24, 2019

Venue: Nanjing International Youth Cultural Center (IYCC)

Specific address: No.8 Yecheng Road, Jianye District, Nanjing

Organizers: WARMTH

Co-organizers: Jiangsu Medical Association, CHINA ISOTOPE & RADIATION ASSOCIATION, Nanjing Medical University and Nanjing First Hosptial

Guest of the Conference
  • Feng Wang

    Feng Wang was born in Changshu, Jiangsu province, China, in 1972. He received his BS in 1991 from China Nanjing Medical University.

  • Kalevi Kairemo

    Prof Kairemo graduated with a MSc(Eng) degree from Helsinki University of Technology in 1980 before undertaking medical training (MD, PhD) at the University of Helsinki, Finland. He undertook specialist training in Clinical Chemistry, Nuclear Medicine, He

  • Zairong Gao

    Zairong Gao, Wuhan Union Hospital, China, Deputy Director of Nuclear Medicine Department of Union Medical College Affiliated to Huazhong University of Science and Technology, Chairman of Nuclear Medicine Branch of Hubei Medical Association,

  • Yingjian Zhang

    Fudan University Shanghai Cancer Center, China, director of the Department of Nuclear Medicine of the Affiliated Tumor Hospital of Fudan University,

  • Yamin Li

    Yamin Li,China Medical University, China

  • Xiaohua Zhu

    Xiaohua Zhu, Tongji Hospital,China

  • Sijin Li

    Sijin Li,Shanxi Medical University, President of Jiangsu Medical Association of Nuclear Medicine Branch, China

  • Yang Zhi

    Yang Zhi is a researcher and doctor of Beijing Cancer Hospital. He is currently the director of Nuclear Medicine Department of Beijing Tumor Hospital

  • Yihui Guan

    Yihui Guan, Huashan Hospital, Fudan University, China

  • Xuemei Wang

    Xuemei Wang,The Affiliated Hospital of Inner,Mongolia Medical University, China

  • Weibo Cai

    Weibo Cai,University of Wisconsin-Madison, USA

  • Mingrong Zhang

    Mingrong Zhang,Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences

  • Zhaohui Zhu

    Zhaohui Zhu,Peking Union Medical College Hospital, China

  • Yansong Lin

    Yansong Lin,Peking Union Medical,College Hospital, China

  • Xiaoli Lan

    Xiaoli Lan,Wuhan Union Hospital,China, MD, post-doctoral fellow.

  • Wei Fang

    Wei Fang,Fuwai Hospital Chinese Academy of Medical Sciences,China

  • XueXian Yan

    Prof. XueXian Yan, Singapore General Hospital, Singapore.

  • Quanyong Luo,

    Quanyong Luo,Shanghai Sixth People 's Hospital, China

  • Mei Tian

    Mei Tian,The Second Affiliated Hospital of Zhejiang University School of Medicine, China

  • Li Huo

    Peking Union Medical College Hospital, China

  • Jing Wang

    Xijing Hospital, China Professor, Chief physician, Director of nuclear medicine, Doctoral tutor

  • Jianqiang Cai

    Cancer Hospital Chinese Academy of Medical Science, China

  • Hong Zhao

    Cancer Hospital Chinese Academy of Medical Sciences, China

  • Jinhua Zhao

    Shanghai General Hospital, China

  • Jianjun Liu

    Ren Ji Hospital Shanghai Jiao Tong University, China

  • Hong Zhang

    The Second Affiliated Hospital of Zhejiang University, China

  • Changjing Zuo

    Changhai Hospital, The Second Military Medical University, China

  • Maode Lai

    China Pharmaceutical University, China

  • Jie Chen

    The First Affiliated Hospital, Sun Yat-sen University, China

  • Hongcheng Shi

    Zhongshan Hospital, Fudan University, China

  • Hui Wang

    Xinhua Hospital Affiliated to Shanghai Jiao Tong University, China

  • Fang Li

    Peking Union Medical College Hospital, China

  • Irene Virgolini

    Irene Virgolini was appointed as a University lecturer (venia docendi) for Experimental Nuclear Medicine in 1992 for her work on functional liver scintigraphy and in 1995 in Internal Medicine (venia docendi) for her work on oncological receptor scintigrap

  • Min Yang.

    Molecular Imaging Center.Jiangsu Institute of Nuclear Medicine.Wuxi, Jiangsu, China.

  • Mingyuan Gao, Ph.D

    Institute of Chemistry, Chinese Academy of Sciences

Schedule of ICRT 2019 Program

August 21st (Wednesday)

Hotel Lobby

(1st Floor)

Room 723

(7th Floor)








Executive Board Meeting


Welcome Reception (Baihua Hall)

August 22nd (Thursday)

Nanjing Hall

(5th Floor)

Honghua Hall A

(5th Floor)

Room 736

(7th Floor)




Session 1: Cardiovascular and Cerebrovascular Diseases


Opening Ceremony



Small Concert (outside Nanjing Hall)


Coffee & Tea Break


Session 2: Theragnostics in Neuroendocrine Tumors

Session 3: Summit

Session 1: Cardiovascular and Cerebrovascular Diseases



Session 4: PRRT in Asia/ Lunch



Session 5: Prostate Cancer

Session 6: Seminar on the Clinical Management of NET

Session 7: Workshop on Nuclear Medicine QC and Clinical Nursing


Coffee & Tea Break


Session 8: Thyroid Cancer

Session 6: Seminar on the Clinical Management of NET




August 23th (Friday)

Nanjing Hall

(5th Floor)

Honghua Hall A

(5th Floor)

Room 736

(7th Floor)


Session 9: New Generation of Theragnostics




Session 10: Seminar on Digital PET/CT and PET/MRI/Global Summit of United Imaging



Coffee & Tea Break


Session 11: Hepatic Cellular Carcinoma Intervention

Session 10: Seminar on Digital PET/CT and PET/MRI/Global Summit of United Imaging





Session 12: The Impact of PSMA Based Theragnostics (Clinical Perspective)/Lunch



Session 13: Molecular Probe and Translations

Session 14: Seminar on Prostate cancer



Session 15: Young Investigator Award on Theragnostics


Coffee & Tea Break


Session 16: PSMA Probe and beyond PSMA

Session 14: Seminar on Prostate cancer

Session 15: Young Investigator Award on Theragnostics





Gala Dinner & Closing Ceremony (Baihua Hall)

August 24th (Saturday)

Room 723

(7th Floor)

Room 736

(7th Floor)

Conference room on the third floor, Building 5, Nanjing First Hospital


Member Assembly Meeting

Session 17: Workshop on Medical Residency Training





Coffee & Tea Break



Session 18: Yangtze River Delta Alliance

Session 19: On-site Training





Session 20: Seminar on PET/CT Imaging Interpretation, The 37th Imaging Interpretation in Jiangsu

Sign Up

TEL : +86 025-52275042

Website :

E-mail :  [email protected]

Registration(OVERSEAS) 注册(国内)

Official WeChat

Official WeChat

Official website of Nanjing Nuclear Medicine and academic conference on molecular markers and nuclear medicine targeted diagnostic therapy

Hospital headquarters Address: No. 68th Changle Road, Nanjing Qinhuai District; Guide Medical Hotline: +86 025-52275042 (8:00-20:00)

Copyright: International Conference On Radiopharmaceutical Therapy

E-mail:[email protected]



Signup Information

The following information is required.